Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Breast Cancer Res Treat. 2016 Jul 18;158(3):523–534. doi: 10.1007/s10549-016-3887-8

Fig. 5.

Fig. 5

Proportion of participants with abnormal breast cancer screening who completed diagnostic evaluation between 180 and 365 days: the Patient Navigation Research Program. N = 1252